Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice

Publication date: Available online 12 January 2021Source: Pharmacology Biochemistry and BehaviorAuthor(s): Kinga K. Borowicz-Reutt, Monika Banach

Source: Pharmacology Biochemistry and Behavior - January 12, 2021 Category: Biochemistry Source Type: research